- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01547026
Self-regulation Strategies to Improve Exercise Behavior Among Schizophrenic Patients
Self-regulation Strategies to Improve Exercise Behavior: A Randomized Clinical Trial in Persons With Schizophrenia Spectrum Disorders
Patients who suffer from diseases of the schizophrenia spectrum are frequently burdened by weight gain. Sport programs have been shown to improve somatic and psychological health. However, the motivation to participate in sports therapy is usually impaired due to illness-related factors such as anhedonia and negative symptoms. Previous attempts to increase participation in sports therapy have used psycho-educational and behavioral attempts that require a lot of resources. In this study the investigators will use a brief method developed in experimental social psychology to build up implementation intentions. This method has been shown to improve psychological test performance in schizophrenia patients but has never been used in a clinical context.
In two psychiatric hospitals, in-patients with schizophrenia who have been examined by a medical doctor, for whom any medical concerns for sports therapy participation have been excluded and who declared their motivation to participate in an existing standard sports exercise program will be recruited for the study. After information on the study and signing of an informed consent patients will be randomly assigned to two treatment conditions. In the control condition, the main therapist will individually deliver a 10-minute psycho-education on the helpfulness of sports to improve the health; this will be repeated in a shorter form in the regular individual treatment sessions over the following weeks. The intervention condition will use a structured procedure of the same duration to build up implementation intentions to participate in the sports therapy. The implementation intentions will briefly be repeated and updated in the following session.
Primary outcome variables will be percentage of attended sport therapy sessions, persistence and compliance. Secondary outcome variables will be Body Mass Index. As confounding variables the investigators will assess amount of anti-psychotic medication in Chlorpromazine equivalents, negative and depressive symptoms, usual sport activities and cognitive impairments.
The investigators expect that building up implementation intentions will increase participation, persistence and compliance of the patients in the sports and exercise therapy program compared to the patients who just have received psycho-education.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Reichenau, Germany, 78479
- Center for Psychiatry Reichenau
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- schizophrenia or schizo-affective disorder
Exclusion Criteria:
- manic episode
- florid positive psychotic symptoms
- catatonic symptoms
- medical concerns for possible damage to patients health by participation in sports therapy
- patient is aggressive
- patient is suicidal
- epilepsia
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Psycho-education
Patients receive a 10 min.
psycho-education on positive health effects of sports
|
In a 10 minute structured therapy session patients are assisted to build up implementation intentions to participate in the sports program.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
percentage of sports therapy sessions attended
Time Frame: max. 8 weeks
|
During a single patient's in-patient treatment, we count the number of sport therapy sessions that were attended and compute a ratio attended/offered sessions
|
max. 8 weeks
|
|
Persistence
Time Frame: max. 8 weeks
|
We assess whether a patient has persisted to participate in successive sports therapy session
|
max. 8 weeks
|
|
Compliance
Time Frame: max. 8 weeks
|
We assess how long the individual patient participates in each therapy session (standard duration 30 min.)
|
max. 8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Body Mass Index (BMI)
Time Frame: max. 8 weeks
|
We use the routine weekly weight measurements of clinic staff to calculate changes of the BMI over the period of participation into the study.
|
max. 8 weeks
|
Collaborators and Investigators
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- UKonstanzMichaelOdenwald2012-1
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Schizophrenia
-
Fundació Institut de Recerca de l'Hospital de la...Recruiting
-
First Affiliated Hospital of Fujian Medical UniversityNot yet recruiting
-
Organon and CoCompletedSchizophrenia, Paranoid | Schizophrenia, Disorganized | Schizophrenia, Undifferentiated
-
Newron Pharmaceuticals SPARecruitingTreatment-resistant SchizophreniaUnited States, India
-
Organon and CoCompletedSchizophrenia, Paranoid | Schizophrenia, Disorganized | Schizophrenia, Undifferentiated
-
Bradley LegaRecruiting
-
All India Institute of Medical Sciences, BhubaneswarCompletedTreatment Resistant SchizophreniaIndia
-
Kaohsiung Medical University Chung-Ho Memorial...Not yet recruitingSchizophrenia Disorder
-
Shanghai Zhongze Therapeutics Co., Ltd.Yale UniversityNot yet recruiting
-
Ole Köhler-ForsbergAarhus University HospitalRecruiting
Clinical Trials on Implementation Intentions
-
University of Colorado, DenverCompletedCollaborative Implementation Intentions | Individual Implementation Intentions | Information Only Control ConditionUnited States
-
Allina Health SystemCompletedTraumatic Brain InjuryUnited States
-
Washington University School of MedicineCompleted
-
University of ManchesterCompleted
-
Duke UniversityTerminatedSmoking Cessation | Perioperative/Postoperative ComplicationsUnited States
-
University of SydneyThe Albion Centre - South Eastern Sydney Local Health DistrictUnknown
-
Trustees of Dartmouth CollegeNational Institute on Drug Abuse (NIDA)CompletedCigarette SmokingUnited States
-
Baylor College of MedicineEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedObesity | CancerUnited States
-
University of SheffieldUniversity of ManchesterCompletedAnger | AggressionUnited Kingdom
-
Inonu UniversityPrincess Nourah Bint Abdulrahman UniversityCompletedSelf-Efficacy | Self-Regulation | Physical Activity Behavior | Sport ParticipationTurkey (Türkiye)